Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Vigil Neuroscience, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 33 | 37 | +4 |
| Shares | 24.6M | 25.0M | +429.2K (+1.7%) |
| Value | $222.7M | $312.3M | +$89.6M (+40.2%) |
New holders (9)
Institutions that held Vigil Neuroscience, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Trustees of Columbia University in the City of New York | 192,973 | $2.41M | 4.97% |
| Bank of Montreal | 58,100 | $726.3K | 0.00% |
| Susquehanna International Group, LLP | 27,375 | $342.2K | 0.00% |
| 683 Capital Management, LLC | 15,092 | $188.7K | 0.02% |
| Bank of America Corp | 9,896 | $123.7K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,832 | $23.0K | 0.00% |
| UBS Group AG | 510 | $6.38K | 0.00% |
| Coppell Advisory Solutions LLC | 300 | – | – |
| Coppell Advisory Solutions Corp. | 300 | – | – |
Sold out (5)
Institutions that held Vigil Neuroscience, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Ergoteles LLC | 28,533 | $260.0K |
| Adage Capital Partners GP, L.L.C. | 22,269 | $203.0K |
| Altium Capital Management LP | 15,788 | $144.0K |
| Royal Bank of Canada | 1,000 | $9.00K |
| JPMorgan Chase & Co | 2 | $0 |